Diagnosis of tuberculosis in developing countries: New perspectives;Diagnostic biologique de la tuberculose dans les pays à faibles ressources: Perspectives nouvelles

Medecine Tropicale

Volumn 69, Issue 6, 2009, Pages 618-628

  Dubrous, P ^a   Alaoui, H ^b   N'Dounga Mikolo, B ^c   Koeck, J L ^a  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^b University Mohammed V   (Mauritius)

^c Service de Biologie Clinique   (Gabon)

Author keywords

Diagnostic techniques; Drug resistance; Tuberculosis

Indexed keywords

DEVELOPING COUNTRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TECHNIQUE; LIQUID CULTURE; REVIEW; SKIN TEST; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; MICROBIOLOGICAL EXAMINATION;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIOLOGICAL TECHNIQUES; MICROSCOPY, FLUORESCENCE; TUBERCULOSIS;

EID: 77649209520     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. World Health Organization. 44th World Health Assembly : resolutions and decisions WHA 44.8. WHA44/1991/REC/1. WHO ed, Geneva, 1991.
2. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. WHO/HTM/TB/2007.376. Geneva 1-270.
3. Squire SB, Belaye AK, Kashoti A, Salaniponi F.M, Mundy CJ, Theobald S et al. "Lost" smear-positive pulmonary tuberculosis cases: where are they and why did we lose them ? Int J Tuberc Lung Dis. 2005; 9 : 25-31. (Pubitemid 40095105)
4. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis: incidence, prevalence and deaths globally. JAMA 2005; 293 : 2767-75. (Pubitemid 40965089)
5. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5 : 1000-5. (Pubitemid 33134749)
6. Perkins MD, Roscigno G, Zumla A. Progress towards improved tuberculosis diagnostics for developing countries. Lancet 2006; 367 : 942-3.
7. Onyebujoh P, Rodriguez W, Mwaba P. Priorities in tuberculosis research. Lancet 2006; 367 : 940-2.
8. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55 : 301-5.
9. Cunningham J, Perkins M. Diagnostics for tuberculosis: global demand and market potential. WHO/TDR Tuberculosis Diagnostics Economic Working Group 2006, Geneva.
10. Stop TB partnership. The global Plan to Stop TB, 2006-2015. www. stoptb.org/ globalplan/assets/documents/stopTB-GlobalPlan-FR-web.pdf
11. http:www.finddiagnostics.org
12. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007; 196; S15-27. (Pubitemid 47206081)
13. Guillerm M, Usdin M, Arkinstall J. Tuberculosis diagnosis and drug sensitivity testing: an overview of the current diagnostic pipeline. Médecins sans frontières, 2006.
14. Keeler E, Perkins MD, Small P, Hanson C, Reed S, Cunningham J et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 2006; 444 : 49-57.
15. Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther 2007; 5 : 327-31. (Pubitemid 47050155)
16. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A., Cunningham J et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6 : 664-74. (Pubitemid 44462695)
17. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6 : 570-81. (Pubitemid 44262344)
18. Kivihya-Ndugga LE, van Cleeff MR, Githui WA, Nganga LW, Kibuga DK, Odhiambo JA et al. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int J Tuberc Lung Dis 2003; 7 : 1163-71. (Pubitemid 38004740)
19. Hung NV, Sy DN, Anthony RM, Cobelens FG, van Soolingen D. Fluorescence microscopy for tuberculosis diagnosis. Lancet Infect Dis 2007; 7 : 238-9. (Pubitemid 46414069)
20. Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, Cunningham J et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007; 11 : 485-95. (Pubitemid 46732633)
21. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005; 99 : 893-900. (Pubitemid 41511449)
22. Svenson SB, Hamasur B, Pawlowski A. Towards development of new point of patient care tuberculosis diagnostics. 37th Union World Conference on Lung Health 2006, Paris, abstract PS-61862-02.
23. Hillemann D, Rüsch-Gerdes S, Richter E. Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2005; 9 : 1409-11.
24. http:www.proteomesystems.com/Discovery/ResearchPrograms/tuberculosis. aspx
25. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. Plos Med 2007; 4 : e202
26. Weldingh K, Rosenkrands J, Okkels LM, Doherty TM, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J Clin Microbiol 2005; 43 : 57-65. (Pubitemid 40096280)
27. Davidow A, Kanaujia GV, Shi L, Kaviar J, Guo X, Sung N et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun 2005; 73 : 6846-51. (Pubitemid 41368852)
28. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6 : 413-22. (Pubitemid 44174345)
29. Nakamura RM, Einck L, Velmonte MA, Kawajiri K, Ang CF, Delasilagas CE et al. Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. Scand J Infect Dis 2001; 33 : 405-7. (Pubitemid 32611418)
30. Geisbrecht BV, Nikonenko B, Samala R, Nakamura R, Nacy CA, Sacksteder KA. Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis. Protein Expr Purif 2006; 46 : 64-72. (Pubitemid 43246997)
31. Phillips M, Cataneo RN, Condos R, Ring Erikson GA, Greenberg J, La Bombardi V et al.Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis 2007; 87 : 44-52. (Pubitemid 44960164)
32. Tobias HJ, Shafer MP, Pitesky M, Fergenson DP, Horn J, Franck M et al. Bioaerosol mass spectrometry for rapid detection of individual airborne Mycobacterium tuberculosis H37Ra particles. Appl Environ Microbiol 2005; 71 : 6086-95. (Pubitemid 41456905)
33. Deisingh AK, Stone DC, Thompson M. Applications of electronic noses and tongues in food analysis. Int J Food Sci Technol 2004; 39 : 587-604. (Pubitemid 38740902)
34. Fend R, Kolk AH, Bessant C, Buijtels P, Klatser PR, Woodman AC. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol 2006; 44 : 2039-45.
35. http:www.apopo.org/technology/tuberculose.htlm
36. Macondo EA, Ba F, Toure-Kane NC, Kaire O, Gueye-Ndiaye A, Gaye-Diallo A et al. Amélioration du diagnostic de la tuberculose par le Mycobacteria Growth Indicator tube (MGIT) dans un laboratoire de pays en dé veloppement. Bull Soc Pathol Exot 2000; 93 : 97-100.
37. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355 : 1539-50. (Pubitemid 44547806)
38. Arias M, Mello FC, Pavón A, Marsico AG, Alvarado-Gálvez C, Rosales S et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44 : 674-80.
39. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45 : 1093-7. (Pubitemid 46626469)
40. Martin A, Portaels F, Palomino JC. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 59 : 175-83. (Pubitemid 47072054)
41. Abate G, Aseffa A, Selassie A, Goshu S, Fekade B, WoldeMeskal D et al. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2004; 42 : 871-3. (Pubitemid 38222685)
42. Piersimoni C, Scarparo C, Cichero P, De Pezzo M, Covelli I., Gesu G et al. Multicenter evaluation of the MB-Redox medium compared with radiometric BACTEC system, mycobacteria growth indicator tube (MGIT), and Löwenstein-Jensen medium for detection and recovery of acid-fast bacilli. Diagn Microbiol Infect Dis 1999; 34 : 293-9. (Pubitemid 29325042)
43. da Silva PA, Boffo MM, de Mattos IG, Silva AB, Palomino JC, Martin A et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006; 12 : 293-6. (Pubitemid 43379334)
44. Affolabi D, Odoun M, Martin A, Palomino JC, Anagonou S, Portaels F. Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol 2007; 45 : 2123-5. (Pubitemid 47203780)
45. Martin A, Montoro E, Lemus D, Simboli N, Morcillo N, Velasco M et al. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis. J Microbiol Methods 2005; 63 : 145-50. (Pubitemid 41443323)
46. Musa HB, Ambroggi M, Souto A, Angeby KA. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy- positive sputum samples. J Clin Microbiol 2005; 43 : 3159-61. (Pubitemid 40981317)
47. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006; 6; 423-32. (Pubitemid 44174346)
48. Baylan O, Kisa O, Albay A, Doganci L. Evaluation of a new automated, rapid, colorimetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int J Tuberc Lung Dis 2004; 8 : 772-7. (Pubitemid 38747155)
49. Kocagoz T, O'Brien R, Perkins M. A new colorimetric culture system for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2004; 8 : 1512.
50. Kocagoz T, Tiryaki S, Silier T, Güney C. TK System, the colorimetric mycobacterial culture system enables rapid, easy and effective diagnosis of tuberculosis [poster] Toronto: ASM General Meeting, May 21-24, 2006.
51. Welch DF, Guruswamy AP, Sides SJ, Shaw CH, Gilchrist MJ. Timely culture for mycobacteria which utilizes a microcolony method. J Clin Microbiol 1993; 31 : 2178-84. (Pubitemid 23210515)
52. Robledo JA, Mejía GI, Morcillo N, Chacón L, Camacho M, Luna J et al. Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int J Tuberc Lung Dis 2006; 10 : 613-9. (Pubitemid 43845021)
53. Flournoy D, Twilley J. Modified Middlebrook 7H9 broth for the rapid detection of mycobacteria. Clin Lab Sci 2001; 14 : 85-8. (Pubitemid 33286244)
54. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect Dis 2005; 5 : 59.
55. Irfan S, Hasan R, Kanji A, Hassan Q, Azam I Evaluation of a microcolony detection method and phage assay for rapid detection of Mycobacterium tuberculosis in sputum samples. Southeast Asian J Trop Med Public Health 2006; 37 : 1187-95.
56. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005; 51 : 175-87. (Pubitemid 41554824)
57. McNerney R, Kambashi BS, Kinkese J, Tembwe R, Godfrey-Faussett P. Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2004 : 42 : 2115-20. (Pubitemid 38637831)
58. Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K et al. Lowcost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 2007; 6 : 1
59. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 2006; 3 : 103-10.
60. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol 2003; 41 : 2616-22. (Pubitemid 36712475)
61. Boehme CC, Nabeta P, Henostroza P, Ragib R, Rahim Z, Gerhardt M et al. Operational feasibility of using loop-mediated isothermal amplification for the diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007; 45 : 1936-40. (Pubitemid 46933929)
62. Goletti D, Cannas A, Chiaccio T, Umanski S, Melkonyan H. Detection of Mycobacterium tuberculosis transrenal DNA from urine samples of patients with pulmonary TB. In : Program and abstracts of 35th World Conference on Lung Health of the International Union Againt Tuberculosis and Lung Disease (Paris). Paris : International Union Against Tuberculosis and Lung Disease. 2005.
63. Lin SY, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smearpositive sputa by use of molecular beacons. J Clin Microbiol 2004; 42 : 4204-8. (Pubitemid 39296145)
64. Piatek AS, Telenti A, Murray MR, El-Hajj H, Jacobs WR Jr, Kramer FR et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000; 44 : 103-10. (Pubitemid 30010679)
65. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smearpositive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006; 44 : 4459-63 (Pubitemid 44940754)
66. Morgan M, Kalentri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin résistance in Mycobacterium tuberculosis : a systematic review and meta-analysis. BMC Infect Dis 2005; 5 : 62.
67. Kim SY, Park YJ, Song E, Jang H, Kim C, Yoo J et al. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006; 54 : 203-10.
68. Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels E. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000; 4 : 481-4. (Pubitemid 30256852)
69. Trébucq A. La lutte contre la tuberculose dans le monde: résultats et défis. Med Trop 2004; 64 : 587-94.
70. Van der Schouw YT, Verbeek AL, Ruijs SH. Guidelines for assessment of new diagnostic tests. Invest Radiol 1995; 30 : 334-40
71. Small PM, Perkins MD. More rigour needed in trials of new diagnostic agents for tuberculosis. Lancet 2000; 356 : 1048-9.
72. OMS. Lignes directrices relatives à la mise en place des projets pilotes "DOTSPlus " pour la prise en charge de la tuberculose à bacilles multirésistants [TB-MR]. WHO/CDS/TB/2000.279.
73. Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H et al. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis 1999; 3 : 643-5. (Pubitemid 29378463)